Gender-specific pharmacology: implications for therapy
- PMID: 17076589
- DOI: 10.4140/tcp.n.2006.620
Gender-specific pharmacology: implications for therapy
Abstract
Historically, research into drugs and diseases has assumed that beyond the reproductive system, gender differences did not exist or were not relevant. Interest in recognizing the importance of gender-based differences in pharmacology and disease has been fueled in recent years by an increasing amount of data revealing variations in drug efficacy and side effect profiles between the genders as well as differences in disease prevalence.
Similar articles
-
Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study.J Epidemiol Community Health. 2001 Sep;55(9):631-8. doi: 10.1136/jech.55.9.631. J Epidemiol Community Health. 2001. PMID: 11511641 Free PMC article.
-
The relationship of socio-environmental factors to the prevalence of obstructive lung diseases and other chronic conditions.J Chronic Dis. 1977 Sep;30(9):599-611. doi: 10.1016/0021-9681(77)90058-3. J Chronic Dis. 1977. PMID: 903391 No abstract available.
-
Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study.BMJ Open. 2017 Jun 22;7(4):e014233. doi: 10.1136/bmjopen-2016-014233. BMJ Open. 2017. PMID: 28646083 Free PMC article.
-
Geriatric pharmacology.Dent Clin North Am. 2002 Oct;46(4):869-85, xii. doi: 10.1016/s0011-8532(02)00025-3. Dent Clin North Am. 2002. PMID: 12436837 Review.
-
Gender differences in pharmacokinetics and pharmacodynamics.Int J Clin Pharmacol Ther. 1999 Nov;37(11):529-47. Int J Clin Pharmacol Ther. 1999. PMID: 10584975 Review.
Cited by
-
Sex-Steroid Signaling in Lung Diseases and Inflammation.Adv Exp Med Biol. 2021;1303:243-273. doi: 10.1007/978-3-030-63046-1_14. Adv Exp Med Biol. 2021. PMID: 33788197 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources